Fredun Pharma Board Meeting on Aug 5 to Approve Q1 FY27 Results

Fredun Pharmaceuticals Ltd has announced that its Board of Directors will convene on August 5, 2026. The primary agenda item for this meeting is to consider and approve the Unaudited Financial Results for the first quarter ended June 30, 2026, for both standalone and consolidated statements. In line with SEBI regulations, the company has also informed that the trading window for its securities will be closed until 48 hours after the declaration of these financial results, to prevent insider trading.